Review Article

Exosomes in the Oncobiology, Diagnosis, and Therapy of Hepatic Carcinoma: A New Player of an Old Game

Table 1

Exosome-mediated cellular interaction involved in liver cancer.

Donor cellsComponentsRecipient cellsFunctionsReferences

HKCI-C3
HKCI-8
MHCC-97L
MET proto-oncogene,
caveolins,
S100 family
MIHAMigration, invasion[13]

Huh7miR-122HepG2Proliferation[14]

HepG2VASNHUVECsMigration[15]

CD90+ Huh7lncRNA H19HUVECsAngiogenesis, adhesion[16]

CAFsmiR-320aMHCC97-HProliferation, migration, metastasis[17]

CSQT-2
HCC-LM3
miR-1247-3pNormal fibroblastsConversion into CAFs[18]

LX-2miR-335MHCC97H, MHCC97L, HepG2 and Huh7Proliferation, invasion, tumor
shrinkage
[19]

Hepa1-6α-AFP,
glypican 3,
HSP 70
DCsT cell activation[20]

Gastric cancerEGFRKupffer cells
HSCs
Liver metastasis[21]

Pancreatic ductal adenocarcinomaMIFKupffer cells
HSCs
Liver metastasis[22]

Breast cancerintegrin αvβ5Kupffer cellsLiver metastasis[23]

Colorectal cancermiR-203M2-TAMsLiver metastasis[24]

MHCC-97HHGFSMCC-7721Chemoresistance[25]

HepG2linc-RORHepG2Chemoresistance[26]

HepG2linc-VLDLRHepG2Chemoresistance[27]

ADMSCsmiR-122HepG2Sorafenib sensistivity[28]

ADMSCs: adipose-derived mesenchymal stem cells; CAFs: cancer associated fibroblasts; DCs: dendritic cells; HSCs: hepatic stellate cells; HUVECs: human umbilical vein endothelial cells; H22: murine hepatocarcinoma cell line; LX-2: hepatic stellate cells line; MIF: macrophage migration inhibitory factor; MIHA: immortalized hepatocyte cell line; and TAMs: tumor-associated macrophages.